CBT Stock Analysis: Buy, Sell, or Hold?
CBT - Cabot Corporation
$89.50
-1.20 (-1.33%)
▼
5d:
+0.32%
30d:
+14.24%
90d:
+30.73%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 6.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CBT shows positive signals but monitor for confirmation. Market pricing in 6.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$105.90
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$65.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $89.50, which is considered extended relative to its 30-day fair value range of $81.37 to $88.80. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.0) compared to its historical average (10.6). At these levels, the market is pricing in 6.8% annual earnings growth.
Technical Outlook: Technically, CBT is in a strong uptrend. Immediate support is located at $81.34, while resistance sits at $93.15.
Market Sentiment: CBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CBT is in a strong uptrend. Immediate support is located at $81.34, while resistance sits at $93.15.
Market Sentiment: CBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$81.37 -
$88.80
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($86.83)
- BULLISH: Expecting earnings turnaround to 6.8% growth with -3.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$81.37 -
$88.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$81.35
Resistance Level
$93.15
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.96
Wall Street Target
$86.83
(-4.3%)
Revenue Growth (YoY)
-3.4%
Earnings Growth (YoY)
-24.9%
Profit Margin
8.0%
Valuation Premium vs History
+6.8% premium
PE vs Historical
13.0 vs 10.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.8%
(market-implied from PE analysis)
1-Year Target
$96.87
(+7%)
2-Year Target
$103.45
(+14%)
3-Year Target
$110.49
(+22%)
3-Yr Target (if PE normalizes)
(PE: 13→11)
PE COMPRESSION
$90.39
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.8%)
$207.65
(+129%)
Base:
(SPY PE: 13.0, Growth: 10.8%)
$123.53
(+36%)
Bear:
(PE: 10.6, Growth: 10.8%)
$101.06
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 17.32 | Current EPS (TTM): $5.30
Bull Case
$133.37
(+47%)
Analyst growth 32.1%, PE expands to 19.1
Base Case
$121.25
(+34%)
Market implied 32.1%, PE stable at 17.3
Bear Case
$62.42
(-31%)
Severe decline -20.0%, PE contracts to 14.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 12:57 PM ET
Data refreshes hourly during market hours. Next update: 1:57 PM
Data refreshes hourly during market hours. Next update: 1:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$545 | 63 BUY |
|
ECL
Ecolab Inc |
STRONG BUY
27 analysts |
$317 | 61 BUY |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$373 | 59 HOLD |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$328 | 62 BUY |
|
IFF
International Flavors & … |
STRONG BUY
19 analysts |
$92 | 63 BUY |
